deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT02434614

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

A Randomized Phase III Non-inferiority Study of Induction Chemotherapy Followed by IMRT Alone Versus Induction Chemotherapy Followed by IMRT Plus Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Sponsor: Guangxi Naxishan Hospital

Conditions Nasopharyngeal Carcinoma
Interventions Cisplatin Docetaxel,Cisplatin,Fluorouracil Intensity-modulated radiation therapy (IMRT)
Updated 10 times since 2017 Last updated: May 10, 2018 Started: Mar 31, 2015 Primary completion: May 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Nasopharyngeal Carcinoma and is currently ongoing. Guangxi Naxishan Hospital leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2020 · 22 months · monthly snapshotActive Not Recruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotActive Not Recruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotUnknown~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotUnknown~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshotUnknown~Dec 2025 – present · 9 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Dec 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2025 — Dec 2025 [monthly]

    Unknown PHASE3

  3. Mar 2025 — Sep 2025 [monthly]

    Unknown PHASE3

  4. Sep 2024 — Mar 2025 [monthly]

    Unknown PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

▶ Show 5 earlier versions

  1. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

  2. Jan 2021 — Mar 2022 [monthly]

    Active Not Recruiting PHASE3

  3. Apr 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  4. Jun 2018 — Apr 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Guangxi Naxishan Hospital
  • Guigang People's Hospital
  • LiuZhou People's Hospital
  • Nanning Monority Hospital
  • Wei Jiang
  • Wuzhou Red Cross Hospital
  • Youjiang Medical College for Nationalities
Data source: Guilin Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations